MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
159 hedge funds and large institutions have $2.01B invested in Momenta Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 60 increasing their positions, 50 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
159
Holders Change
-1
Holders Change %
-0.63%
% of All Funds
3.64%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
60
Reduced
50
Closed
15
Calls
$3.86M
Puts
$2.48M
Net Calls
+$1.38M
Net Calls Change
-$272K
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$57.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$16M |
| 3 |
BlackRock
New York
|
+$10.5M |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.39M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.37M |
Top Sellers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$56.4M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$14.9M |
| 3 |
State Street
Boston,
Massachusetts
|
-$9.91M |
| 4 |
D.E. Shaw & Co
New York
|
-$7.22M |
| 5 |
TA
Teachers Advisors
New York
|
-$6.64M |
